SCHEMBL18106938

SCHEMBL18106938

OC1CCN(c2nncc(-c3ccccc3)n2)CC1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.69
NPC1 O15118 2/20 0.69
RAB9A P51151 1/20 0.69
MAPT P10636 4/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CYP11B2 P19099 8/20 0.47
GAA P10253 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
GLA P06280 2/20 0.44
POLB P06746 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.44
NEK2 P51955 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17207668 0.86 CYP11B2 (0.61) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3451175 0.82 HPGD (0.56) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL18508434 0.82 ALDH1A1 (1.00) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL20402779 0.79 ALDH1A1 (0.73) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3451637 0.76 HPGD (0.50) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL17207584 0.72 CYP11B2 (0.58) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL17207694 0.72 CYP11B2 (0.63) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL17207569 0.71 CYP11B2 (0.66) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3451507 0.70 ADORA1 (0.60) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3452078 0.70 HPGD (0.47) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560963-B1 PYRAZINE DERIVATIVES AS INHIBITORS OF THE ENZYME SCD-1 FOR THE TREATMENT OF CANCER DISEASES AND DIABETES PF MEDICAMENT (FR) 2016-10-05 EP disclosed